FDA Delay Forces Kezar Life Sciences to Close Its Doors
A four-month FDA meeting cancellation proved fatal for Kezar Life Sciences, highlighting how regulatory delays can devastate small biotech companies.
Fda Regulation
2 articles tagged "Fda Regulation"
FDA Eyes Reversal on Peptide Compounding Ban
The FDA signals a reversal of its 2023 peptide compounding ban, raising patient safety concerns, while gene therapy researchers face manufacturing hurdles.
By James Liu